Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IBI3003 |
Trade Name | |
Synonyms | IBI-3003|IBI 3003 |
Drug Descriptions |
Limited information is currently available on IBI3003, a putative T-cell engager therapy targeting GPRC5D and BCMA (Oct 2023). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IBI3003 | IBI3003 | 0 | 1 |